Raymond James:Trupanion (TRUP) Valuation Insights

September 8, 2018 - By Ash Maslow

Trupanion, Inc. (NASDAQ:TRUP) Logo

How Raymond James Currently Rates Trupanion (TRUP)

In an analyst report issued to clients on Friday, 7 September, Raymond James analyst just started coverage of Trupanion (TRUP) with “Outperform” rating.

The stock decreased 2.35% or $0.88 during the last trading session, reaching $36.49. About 473,919 shares traded or 50.68% up from the average. Trupanion, Inc. (TRUP) has risen 84.23% since September 8, 2017 and is uptrending. It has outperformed by 71.66% the S&P500.

Analysts await Trupanion, Inc. (NASDAQ:TRUP) to report earnings on November, 1. They expect $-0.01 EPS, down 200.00 % or $0.02 from last year’s $0.01 per share. After $-0.01 actual EPS reported by Trupanion, Inc. for the previous quarter, Wall Street now forecasts 0.00 % EPS growth.

Trupanion, Inc., together with its subsidiaries, provides medical insurance plans for cats and dogs on monthly subscription basis in the United States, Canada, and Puerto Rico. The company has market cap of $1.21 billion. It serves pet owners and veterinarians through third-party referrals and online member acquisition channels. It currently has negative earnings. The firm was formerly known as Vetinsurance International, Inc. changed its name to Trupanion, Inc. in 2013.

More recent Trupanion, Inc. (NASDAQ:TRUP) news were published by: Seekingalpha.com which released: “Trupanion: A Moonshot Valuation With Lingering Questions” on August 21, 2018. Also Benzinga.com published the news titled: “Trupanion Has Large Opportunity In Growing $1B Pet Insurance Market, Raymond James Says In Bullish Initiation” on September 07, 2018. Benzinga.com‘s news article titled: “Benzinga’s Top Upgrades, Downgrades For September 7, 2018” with publication date: September 07, 2018 was also an interesting one.

Trupanion, Inc. (NASDAQ:TRUP) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.